| Income Statement |
| Operating Expenses | 11.36M |
|
| Research and Development Expense | 36.00K |
| Selling, General and Administrative Expense | 2.91M |
| Operating Income | -11.36M |
| Net Income | -13.02M |
| Net Income Common Stock | -13.02M |
| Net Income Common Stock (USD) | -13.02M |
| Consolidated Income | -13.02M |
| Earnings per Basic Share | -0.38 |
| Earnings per Basic Share (USD) | -0.38 |
| Earnings per Diluted Share | -0.38 |
| Earning Before Interest & Taxes (EBIT) | -13.02M |
| Earning Before Interest & Taxes (USD) | -13.02M |
| Weighted Average Shares | 34.60M |
| Weighted Average Shares Diluted | 34.60M |
| Balance Sheet |
| Cash and Equivalents | 5.71M |
| Cash and Equivalents (USD) | 5.71M |
| Investments | 35.90M |
| Investments Non-Current | 35.90M |
| Current Assets | 6.14M |
| Total Assets | 42.69M |
| Current Liabilities | 1.07M |
| Total Liabilities | 1.07M |
| Accumulated Retained Earnings (Deficit) | -475.31M |
| Shareholders Equity | 41.62M |
| Shareholders Equity (USD) | 41.62M |
| Assets Non-Current | 36.55M |
| Trade and Non-Trade Payables | 261.00K |
| Cash Flow |
| Net Cash Flow from Financing | -2.90M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.84M |
| Issuance (Purchase) of Equity Shares | -2.90M |
| Net Cash Flow from Investing | 2.23M |
| Net Cash Flow - Investment Acquisitions and Disposals | 2.23M |
| Net Cash Flow from Operations | -1.16M |
| Share Based Compensation | 500.00K |